BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26552458)

  • 1. Clinical manifestations of pneumonia according to the causative organism in patients in the intensive care unit.
    Lee JK; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
    Korean J Intern Med; 2015 Nov; 30(6):829-36. PubMed ID: 26552458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
    Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
    Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiological features of patients admitted to the intensive care unit with nursing and healthcare-associated pneumonia.
    Lee MK; Kim SH; Yong SJ; Shin KC; Park HC; Choi J; Choi YS; Seong JH; Jung YR; Lee WY
    J Int Med Res; 2015 Apr; 43(2):236-49. PubMed ID: 25563575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.
    Leão AC; Menezes PR; Oliveira MS; Levin AS
    BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
    Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
    Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.
    Verhamme KM; De Coster W; De Roo L; De Beenhouwer H; Nollet G; Verbeke J; Demeyer I; Jordens P
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):389-97. PubMed ID: 17385143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
    Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia.
    Lakbar I; Medam S; Ronflé R; Cassir N; Delamarre L; Hammad E; Lopez A; Lepape A; Machut A; Boucekine M; Zieleskiewicz L; Baumstarck K; Savey A; Leone M;
    Sci Rep; 2021 Aug; 11(1):16497. PubMed ID: 34389761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.
    Tumbarello M; De Pascale G; Trecarichi EM; Spanu T; Antonicelli F; Maviglia R; Pennisi MA; Bello G; Antonelli M
    Intensive Care Med; 2013 Apr; 39(4):682-92. PubMed ID: 23370828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe community-acquired pneumonia admitted at the intensive care unit: main clinical and bacteriological features and prognostic factors: a Tunisian experience].
    Fekih Hassen M; Ben Haj Khalifa A; Tilouche N; Ben Sik Ali H; Ayed S; Kheder M; Elatrous S
    Rev Pneumol Clin; 2014 Oct; 70(5):253-9. PubMed ID: 24874404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study.
    Nazer LH; Kharabsheh A; Rimawi D; Mubarak S; Hawari F
    Microb Drug Resist; 2015 Oct; 21(5):556-61. PubMed ID: 26430944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
    Kang CI; Chung DR; Peck KR; Song JH;
    Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.